Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Non-Current Assets data on file, last reported at $135.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 19.2% year-over-year to $135.4 million; the trailing twelve-month figure through Mar 2026 stood at $485.1 million (up 11.21% YoY), and the FY2025 full-year result was $118.6 million, up 7.86% from the prior year.
• Non-Current Assets improved to $135.4 million in Q1 2026, from $118.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $135.4 million in Q1 2026 to a low of $3.4 million in Q1 2022.
• A 5-year average of $80.9 million and a median of $90.1 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 2504.44% in 2023 and declined 3.85% in 2025, its largest moves.
• Tracing CATX's Non-Current Assets over 5 years: stood at $4.9 million in 2022, then soared by 1562.31% to $81.1 million in 2023, then soared by 35.64% to $109.9 million in 2024, then grew by 7.86% to $118.6 million in 2025, then rose by 14.2% to $135.4 million in 2026.
• Business Quant data shows CATX's Non-Current Assets at $135.4 million in Q1 2026, $118.6 million in Q4 2025, and $116.3 million in Q3 2025.